2003/10 - 2004/08 Associate Professor, Faculty of Medicine, Saga University
2004/09 - 2007/03 Associate Professor, Medicine, Faculty of Medicine, Saga University
2007/04 - 2013/06 Associate Professor, Medicine, Faculty of Medicine, Saga University
2013/07 - 2014/03 Associate Professor, Center for Comprehensive Community Medicine, Center for Comprehensive Community Medicine, Faculty of Medicine, Saga University
2014/04 - 2015/08 Associate Professor, Organization for General Education, Organization for General Education, Saga University
2015/09 - * Professor, Organization for General Education, Organization for General Education, Saga University
Field of Specialization
Hematology, Structural biochemistry
Research Topics and Results
Hemostatic and protein C pathway dysfunction in the pathogenesis of experimental cerebral malaria. 2022/08
Hydrothermal processing of ホイ-glucan from Aureobasidium pullulans produces a low molecular weight reagent that regulates inflammatory responses induced by TLR 2019/04
Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice. 2016
水熱処理法で精製した黒酵母βグルカンによるマクロファージ活性化の抑制 2016
Inhibition of antibody production in vivo by pre-stimulation of Toll-like receptor 4 before antigen priming is caused by defective B-cell priming and not impairment in antigen presentation 2013
Reduced surface expression of TLR4 by a V254I point mutation accounts for the low lipopolysaccharide responder phenotype of BALB/c B cells. 2013
Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae 2013
Inhibition of primary but not secondary humoral immune responses by pre-injection of an agonistic anti-TLR4/MD-2 antibody. 2011/11
Agonistic anti-TLR4 monoclonal antibodies function as immunoadjuvants. 2010/08
Lipopolysaccharide- bindingprotein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. 2010/08
Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells. 2010
Organotypic culture of human bone marrow adipose tissue. 2010
Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo. 2010
Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function. 2010
Oligomerization-independent TLR4-signaling in CD14-negative cells 2007/11
Adjuvant effects of agonistic anti-TLR4 monoclonal antibody in antibody induction 2007/11
プロテインC受容体(EPCR) 2007/09
Preparation of recombinant murine tumor necrosis factor-alpha in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography. 2007
Preparation and Characterization of Agonistic Monoclonal Antibodies Against Toll-Like Receptor 4-MD-2 Complex. 2007
The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1 2005
Preparation and Characterization of Monoclonal Antibodies to Thrombomodulin 2005
Comparison of Lipopolysaccharide-Binding Functions of CD14 and MD-2 2005
Hemostatic and protein C pathway dysfunction in the pathogenesis of experimental cerebral malaria.; 2022/08 ANNOUNCEMENT INFO.; , 107, 8, 1950-1954 AUTHOR; O'Regan N, Gegenbauer K, Gleeson EM, Fukudome K, O'Sullivan JM, Drakeford C, Dalton N, Chion A, Brophy TM, Smith OP, Preston RJS, O'Donnell JS.
Hydrothermal processing of ホイ-glucan from Aureobasidium pullulans produces a low molecular weight reagent that regulates inflammatory responses induced by TLR; 2019/04 ANNOUNCEMENT INFO.; Biochem Biophys Res Commun., 511, 2, 318-322 AUTHOR; Hayashi N, Shoubayashi Y, Kondo N, Fukudome K.
Toll-Like Receptor 4 Agonistic Antibody Promotes Host Defense against Chronic Pseudomonas aeruginosa Lung Infection in Mice.; 2016 ANNOUNCEMENT INFO.; Infection and Immunity, 84, 7, 1986-93 AUTHOR; Nakamura S, Iwanaga N, Seki M, Fukudome K, Oshima K, Miyazaki T, Izumikawa K, Yanagihara K, Miyazaki Y, Mukae H, Kohno S
Inhibition of antibody production in vivo by pre-stimulation of Toll-like receptor 4 before antigen priming is caused by defective B-cell priming and not impairment in antigen presentation; 2013 ANNOUNCEMENT INFO.; Int Immunol. 2013 Feb;25(2):117-28., 25, 2, 117-128 AUTHOR; Rachmawati NM, Fukudome K, Tsuneyoshi N, Bahrun U, Tsukamoto H, Yanagibashi T, Nagai Y, Takatsu K, Ohta S, Kimoto M.
Reduced surface expression of TLR4 by a V254I point mutation accounts for the low lipopolysaccharide responder phenotype of BALB/c B cells.; 2013 ANNOUNCEMENT INFO.; J Immunol., 190, 1, 195-204 AUTHOR; Tsukamoto H, Fukudome K, Takao S, Tsuneyoshi N, Ohta S, Nagai Y, Ihara H, Miyake K, Ikeda Y, Kimoto M.
Toll-like receptor 4 agonistic antibody promotes innate immunity against severe pneumonia induced by coinfection with influenza virus and Streptococcus pneumoniae; 2013 ANNOUNCEMENT INFO.; Clin Vaccine Immunol., 20, 7, 977-985 AUTHOR; Tanaka A, Nakamura S, Seki M, Fukudome K, Iwanaga N, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Yanagihara K, Kohno S.
Lipopolysaccharide-binding protein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.; 2010 ANNOUNCEMENT INFO.; Int Immunol., 22, 4, 271-280 AUTHOR; Tsukamoto H, Fukudome K, Takao S, Tsuneyoshi N, Kimoto M
Organotypic culture of human bone marrow adipose tissue.; 2010 ANNOUNCEMENT INFO.; Pathol Int., 60, 4, 259-267 AUTHOR; Uchihashi K, Aoki S, Shigematsu M, Kamochi N, Sonoda E, Soejima H, Fukudome K, Sugihara H, Hotokebuchi T, Toda S.
Blocking endothelial protein C receptor (EPCR) accelerates thrombus development in vivo.; 2010 ANNOUNCEMENT INFO.; Thromb Haemostasis. 103(6):1239-44., 103, 6, 1239-1244 AUTHOR; Centelles MN, Puy C, L�pez-Sagaseta J, Fukudome K, Montes R, Hermida J.
Activated protein C utilizes the angiopoietin/Tie2 axis to promote endothelial barrier function.; 2010 ANNOUNCEMENT INFO.; FASEB J., 24, 3, 873-881 AUTHOR; Minhas N, Xue M, Fukudome K, Jackson CJ.
Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects.; 2009 ANNOUNCEMENT INFO.; Haematologica, 94, 3, 387-94, 94, 3, 387-394 AUTHOR; *P�rez-Casal M, Downey C, Cutillas-Moreno B, Zuzel M, Fukudome K, Toh CH.
Effect of disease activity and corticosteroids on serum levels of soluble endothelial cell protein C receptor in patients with systemic lupus erythematosus.; 2009 ANNOUNCEMENT INFO.; Mod Rteumatol.19.2.173-9, 19, 2, 173-179 AUTHOR; ○Koarada S, Tsuneyoshi N, Haruta Y, Tada Y, Mitamura M, Inoue H, Ohta A, Fukudome K, Nagasawa K.
Penta-acylated lipopolisaccharide binds to murine MD-2 but does not induce the oligomelization of TLR4 required for signal transduction.; 2007 ANNOUNCEMENT INFO.; Cellular Immunology , 244, 1, 57-64 AUTHOR; Tsuneyoshi N, Kohara J, Bahrun U, Saitoh S-I, Akashi S, Gauchat J-F, Kimoto M, Fukudome K
Preparation of recombinant murine tumor necrosis factor-alpha in Escherichia coli: a rapid method to remove tags from fusion proteins by thrombin-cleavage and ion-exchange chromatography.; 2007 ANNOUNCEMENT INFO.; Protein Expr Purif.(Academic Press), 56, 1, 138-144 AUTHOR; Tsukamoto H, Fukudome K, Kohara J, Nakatake H, Kimoto M
Preparation and Characterization of Agonistic Monoclonal Antibodies Against Toll-Like Receptor 4-MD-2 Complex.; 2007 ANNOUNCEMENT INFO.; Hybridoma(Mary Ann Liebert, Inc.), 26, 6, 393-399 AUTHOR; Bahrun U, Kimoto M, Tsukamoto H, Tsuneyoshi N, Kohara J, Fukudome K
Expression of CD180, a Toll-like receptor homologue, is up-regulated in children with Kawasaki disease.; 2006 ANNOUNCEMENT INFO.; J. Mol. Med., 84, 2, 168-174 AUTHOR; Imayoshi M, Yamamoto S, Watanabe M, Nishimura S, Tashiro K, Zaitsu M, Takaski H, Kimoto M, Hamasaki Y, Ishii E
Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli.; 2006 ANNOUNCEMENT INFO.; Protein Expr Purif. , 49, 2, 276-283 AUTHOR; Kohara J, Tsuneyoshi N, Gauchat JF, Kimoto M, Fukudome K
Recombinant human activated protein C upregulates the release of soluble fractalkine from human endothelial cells.; 2006 ANNOUNCEMENT INFO.; Br J Haematol. , 133, 5, 550-557 AUTHOR; Brueckmann M, Nahrup AS, Lang S, Bertsch T, Fukudome K, Liebe V, Kaden JJ, Hoffmann U, Borggrefe M, Huhle G
Induction of long-term lipopolysacchride tolerance by an agonistic monoclonal antibody to the Toll-like receptor 4/MD-2 complex.; 2006 ANNOUNCEMENT INFO.; Clin Vaccine Immunol., 13, 10, 1131-1136 AUTHOR; Ohta S, Bahrun U, Shimazu R, Matsushita H, Fukudome K, Kimoto M
Thrombus and encapsulated hematoma in cerebral cavernous malformations; 2005 ANNOUNCEMENT INFO.; ACTA NEUROPATHOLOGICA, 109, 5, 503-509 AUTHOR; Abe, M / Fukudome, K / Sugita, Y / Oishi, T / Tabuchi, K / Kawano, T
Activated protein C induces the release of microparticle-associated endothelial protein C receptor; 2005 ANNOUNCEMENT INFO.; BLOOD, 105, 4, 1515-1522 AUTHOR; Perez-Casal, M / Downey, C / Fukudome, K / Marx, G / Toh, C. HToh
The functional and structural properties of MD-2 required for lipopolysaccharide binding are absent in MD-1; 2005 ANNOUNCEMENT INFO.; JOURNAL OF IMMUNOLOGY, 174, 1, 340-344 AUTHOR; Tsuneyoshi, N / Fukudome, K / Kohara, J / Tomimasu, R / Gauchat, J.-F / Nakatake, H / Kimoto, M
Recombinant human activated protein C upregulates cyclooxygenase-2 expression in endothelial cells via binding to endothelial cell protein C receptor and activation of protease-activated receptor-1; 2005 ANNOUNCEMENT INFO.; Thromb Haemost, 93, 743-750 AUTHOR; Brueckmann, M., S. Horn, S. Lang, K. Fukudome, A. Schulze Nahrup, U. Hoffmann, J.J. Kaden, M. Borggrefe, K.K. Haase, and G. Huhle
Preparation and Characterization of Monoclonal Antibodies to Thrombomodulin; 2005 ANNOUNCEMENT INFO.; HYBRIDOMA AND HYBRIDOMICS, 24, 4, 189-196 AUTHOR; Tsuneyoshi, N / Fukudome, K / Higuchi, K / Kimoto, M
Anti-inflammatory effect of activated protein C in gastric epithelial cells; 2005 ANNOUNCEMENT INFO.; JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 3, 12, 2721-2729 AUTHOR; NAKAMURA, M / GABAZZA, E. C / IMOTO, I / YANO, Y / TAGUCHI, O / HORIKI, N / Fukudome, K / SUZUKI, K / ADACHI, Y.
Comparison of Lipopolysaccharide-Binding Functions of CD14 and MD-2; 2005 ANNOUNCEMENT INFO.; CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 12, 11, 1292-1297 AUTHOR; Koraha, J / Tsuneyoshi, N / Kimoto, M / Gauchat, J.-F / Nakatake, H / Fukudome, K
Endothelial Protein C Receptor and Protease-Activated Receptor-1 Mediate Induction of a Wound-Healing Phenotype in Human Keratinocytes by Activated Protein C; 2005 ANNOUNCEMENT INFO.; JOURNAL OF INVESTIGATIVE DERMATOLOGY, 125, 6, 1279-1285 AUTHOR; Xue, M / Campbell, D / Sambrook, P. N / Fukudome, K / Jackson, C. J
Autoantibodies against EPCR are found in antiphospholipid syndrome and are a risk factor for fetal death; 2004 ANNOUNCEMENT INFO.; BLOOD, 104, 5, 1369-1374 AUTHOR; Hurtado, V / Montes, R / Gris, J.-C / Bertolaccini, M. L / Alonso, A / Martinez-Gonzalez, M. A / Khamashta, M. A / Fukudome, K / Lane, D. A. / Hermida, J.
Activated Protein C Induces Endothelial Cell Proliferation by Mitogen-Activated Protein Kinase Activation In Vitro and Angiogenesis In Vivo; 2004 ANNOUNCEMENT INFO.; CIRCULATION RESEARCH, 95, 1, 34-41 AUTHOR; Uchiba, M / Okajima, K / Oike, Y / Ito, Y / Fukudome, K / Isobe, H / Suda, T
Activated protein C inhibits bronchial hyperresponsiveness and Th2 cytokine expression in mice.; 2004 ANNOUNCEMENT INFO.; Blood, 103, 2196-2204 AUTHOR; Yuda H,Adachi Y,Taguchi O,Gabazza EC,Hataji O,Fujimoto H,Tamaki S,Nishikubo K,Fukudome K,D'Alessandro-Gabazza CN,Maruyama J,Izumizaki M,Iwase M,Homma I,Inoue R,Kamada H,Hayashi T,Kasper M,Lambrecht BN,Bames PJ,SuzukiK.
MAb PS7 against human protein S; 2004 ANNOUNCEMENT INFO.; Hybridoma and Hybridomics 23:389, 2004 AUTHOR; Tsuneyoshi N,Fukudome K,Kimoto M
Current Topics of EPCR; 2003/12 ANNOUNCEMENT INFO.; , 14, 6, 511-513 AUTHOR;
Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective; 2003 ANNOUNCEMENT INFO.; NATURE MEDICINE, 9, 3, 338-342 AUTHOR; Cheng, T / Liu, D / Griffin, J. H / Fernandez, J. A / Castellino, F / Rosen, E. D / Fukudome, K / Zlokovic, B. V
Activated protein C alters cytosolic calcium flux in human brain endothelium via binding to endothelial protein C receptor and activation of protease activated receptor-1; 2003 ANNOUNCEMENT INFO.; BLOOD, 101, 12, 4797-4801 AUTHOR; Domotor, E / Benzakour, O / Griffin, J. H / Yule, D / Fukudome, K / Zlokovic, B. V
Activated protein C inhibits the expression of platelet-derived growth fador in the lung.; 2003 ANNOUNCEMENT INFO.; Am. J. Respir. Crit. Care Med., 167, 10, 1416-1426 AUTHOR; Shimizu S,Gabazza EC,Taguchi O,Yasui H,Taguchi Y,Hayashi T,Ido M,Shimizu T,Nakagaki T,Kobayashi H,Fukudome K,Tsuneyoshi N,D'Alessandro-Gabazza CN,Izumizaki, Iwase M,Homma I,Adachi Y,Suzuki K.
Expression and function of the endothelial protein C receptor in human neutrophils; 2003 ANNOUNCEMENT INFO.; BLOOD, 102, 4, 1499-1505 AUTHOR; Sturn, D / H. Kaneider, N. C / Feistritzer, C / Djanani, A / Fukudome, K / Wiedermann, C. J.
Characterization of protein C receptor expression in monocytes.; 2001 ANNOUNCEMENT INFO.; Br. J. Haematol. , 115, 408-414 AUTHOR; Galligan L, Livingstone W, Volkov Y, Hokamp K, Murphy C, Lawler M, Fukudome K and Smith O
Expression and anticoagulant function of the endothelial cell protein C receptor (EPCR) in cancer cell lines.; 2001 ANNOUNCEMENT INFO.; Thromb. Haemost. , 895, 356-361 AUTHOR; Tsuneyoshi N, Fukudome K, Horiguchi S, Ye X, Matsuzaki M, Toi M, Suzuki K and Kimoto M
Regulatory roles for CD14 and phosphatidylinositol in the signaling via toll-like receptor 4-MD-2.; 2000 ANNOUNCEMENT INFO.; Biochem. Biophys. Res. Commu., 268, 172-177 AUTHOR; Akashi S, Ogata H, Kirikae F, Kirikae T, Kawasaki K, Nishijima M, Shimazu R, Nagai Y, Fukudome K, Kimoto M and Miyake K
Anti-adhesive function of CD43 130 kDa glycoform expressed in CD4 T lymphocyte clones and in transfectant cell lines.; 2000 ANNOUNCEMENT INFO.; Blood , 96, 4267-4275 AUTHOR; Fukuoka M, Fukudome K, Yamashita Y, Tokushima M, Miyake K and Kimoto M
Characterization and regulation of the 5'-flanking region of the murine endothelial protein C receptor gene.; 2000 ANNOUNCEMENT INFO.; J. Biol. Chem. , 275, 12481-12488 AUTHOR; Gu JM, Fukudome K and Esmon CT
Activated protein C suppresses tissue factor expression on U937 cells in the endothelial protein C receptor-dependent manner.; 2000 ANNOUNCEMENT INFO.; FEBS Lett. , 477, 3, 208-212 AUTHOR; Shua F, Kobayashia H, Fukudome K, Tsuneyoshi N, Kimoto M and Terao T
Inflammation, sepsis and coagulation.; 1999 ANNOUNCEMENT INFO.; Haematologica , 84, 3, 254-259 AUTHOR; Esmon CT, Fukudome K, Mather T, Bode W, Rega LM, Stearns-Kurosawa DJ and Kurosawa S
MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4.; 1999 ANNOUNCEMENT INFO.; J. Exp. Med. , 189, 1777-1782 AUTHOR; Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, Miyake K and Kimoto M
Fibroblasts, glial, and neuronal cells are involved in extravascular prothrombin activation.; 1999 ANNOUNCEMENT INFO.; J Biochem , 126, 4, 655-661 AUTHOR; Yamazaki Y, Shikamoto Y, Fukudome K, Kimoto M, Morita T
The endothelial cell protein C receptor (EPCR) functions as a primary receptor for protein C activation on endothelial cells in arteries, veins, and capillaries.; 1999 ANNOUNCEMENT INFO.; Biochem Biophys Res Commun. , 259, 3, 671-677 AUTHOR; Ye X, Fukudome K, Tsuneyoshi N, Satoh T, Tokunaga O, Sugawara K, Mizokami H, Kimoto M
Activation mechanism of anticoagulant protein C in large blodd vessels involving the endothelial cell protein C receptor.; 1998 ANNOUNCEMENT INFO.; J. Exp. Med. , 187, 1029-1035 AUTHOR; 2. Fukudome K, Ye X, Tsuneyoshi N, Tokunaga O, Sugawara K, Mizokami H and Kimoto M
The endothelial cell protein C receptor: Cell Surface expression and direct ligand binding by the solubule receptor; 1996 ANNOUNCEMENT INFO.; J. Biol. Chem., 271, 17491-17498 AUTHOR; Fukudome K, Kurosawa S, Stearns-Kurosawa DJ, He X, Rezaie AR, Esmon CT
The endothelial cell protein C receptor: Inhibition of activated protein C antiacoagulant functiiion without modulation of reaction with protease inhibitors.; 1996 ANNOUNCEMENT INFO.; J. BIol. Chem, 271, 17499-17503 AUTHOR; Regan LM, Sterns-Kurosawa DJ, Kurosawa S, Molica J, Fukudome K Esmon CT
Inhibition of primary but not secondary humoral immune responses by pre-injection of an agonistic anti-TLR4/MD-2 antibody.; 2011/11 ANNOUNCEMENT INFO.; AUTHOR; Rachmawati NM, Fukudome K, Tsuneyoshi N, Uleng B, Ohta S, Kimoto M
Agonistic anti-TLR4 monoclonal antibodies function as immunoadjuvants.; 2010/08 ANNOUNCEMENT INFO.; 14th International Congress of Immunology 2010, 8, 22-27 AUTHOR; Rachmawati NM, Uleng B, Fukudome K, Kimoto M
Lipopolysaccharide- bindingprotein-mediated Toll-like receptor 4 dimerization enables rapid signal transduction against lipopolysaccharide stimulation on membrane-associated CD14-expressing cells.; 2010/08 ANNOUNCEMENT INFO.; 14th International Congress of Immunology 2010, 8, 22-27 AUTHOR; Tsukamoto H, Fukudome K, Takao S, Tsuneyoshi N, Kimoto M.
Binding characteristics of MD proteins to lpopolysaccharide.; 2004/07 ANNOUNCEMENT INFO.; 12th International Congress of Immunology 2004,7,21. Online Abstracts (http://www.immuno2004.org/onlineabstracts/allposters/1684.html) AUTHOR; Fukudome K, Tsuneyoshi N, Tomimasu R, Kohara J, Gauchat F, Kimoto M
A novel isoform of MD-2 that regulates LPS signaling.; 2004/02 ANNOUNCEMENT INFO.; 10th International Conference on Lymphocyte Activation and Immune Regulation 2004,2,6. Abstracts, 3 AUTHOR; Ohta S, Bahrun U, Fukudome K, Kimoto M
Expression of MD-1 protein in CHO cells.; 2003 ANNOUNCEMENT INFO.; 第76回生化学会大会 2003,10,16. 生化学, 75, 873 AUTHOR; Tsuneyoshi N, Tomimasu R, Fukudome K, Kimoto M
Anti-adhesive function of CD43 130-kDa glycoform.; 2001 ANNOUNCEMENT INFO.; 11th International Congress of Immunology 2001,7,27. Program , 28 AUTHOR; Kimoto M, Fukudome K, Yamashita Y, Tokushima M, Miyake K, Fukuoka M
Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor.; 2000/06 ANNOUNCEMENT INFO.; 15th International Congress of Fibrinolysis and Proteolysis 2000,6,29. Program , 51 AUTHOR; Fukudome K
Molecular mechanism for protein C activation.; 1999 ANNOUNCEMENT INFO.; The first Aso International Meeting 1999,11.19. Abstract, 8-9 AUTHOR; Fukudome K